Literature DB >> 21632210

Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.

David Luckey1, Dikshya Bastakoty, Ashutosh K Mangalam.   

Abstract

Multiple sclerosis (MS), an inflammatory and demyelinating autoimmune disease of CNS has both, a genetic and an environmental predisposition. Among all the genetic factors associated with MS susceptibility, HLA class II haplotypes such as DR2/DQ6, DR3/DQ2, and DR4/DQ8 show the strongest association. Although a direct role of HLA-DR alleles in MS have been confirmed, it has been difficult to understand the contribution of HLA-DQ alleles in disease pathogenesis, due to strong linkage disequilibrium. Population studies have indicated that DQ alleles may play a modulatory role in the progression of MS. To better understand the mechanism by which HLA-DR and -DQ genes contribute to susceptibility and resistance to MS, we utilized single and double transgenic mice expressing HLA class II gene(s) lacking endogenous mouse class II genes. HLA class II transgenic mice have helped us in identifying immunodominant epitopes of PLP in context of various HLA-DR and -DQ molecules. We have shown that HLA-DR3 transgenic mice were susceptible to PLP(91-110) induced experimental autoimmune encephalomyelitis (EAE), while DQ6 (DQB1*0601) and DQ8 (DQB1*0302) transgenic mice were resistant. Surprisingly DQ6/DR3 double transgenic mice were resistant while DQ8/DR3 mice showed higher disease incidence and severity than DR3 mice. The protective effect of DQ6 in DQ6/DR3 mice was mediated by IFNγ, while the disease exacerbating effect of DQ8 molecule was mediated by IL-17. Further, we have observed that myelin-specific antibodies play an important role in PLP(91-110) induced EAE in HLA-DR3DQ8 transgenic mice. Based on these observations, we hypothesize that epistatic interaction between HLA-DR and -DQ genes play an important role in predisposition to MS and our HLA transgenic mouse model provides a novel tool to study the effect of linkage disequilibrium in MS.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632210      PMCID: PMC3173604          DOI: 10.1016/j.jaut.2011.05.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  71 in total

1.  HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis.

Authors:  C Alvarado-de la Barrera; J Zúñiga-Ramos; J A Ruíz-Morales; B Estañol; J Granados; L Llorente
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

2.  HLA-DR15 is associated with lower age at onset in multiple sclerosis.

Authors:  T Masterman; A Ligers; T Olsson; M Andersson; O Olerup; J Hillert
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

Review 3.  Animal models for autoimmune demyelinating disorders of the nervous system.

Authors:  R Gold; H P Hartung; K V Toyka
Journal:  Mol Med Today       Date:  2000-02

4.  Haralampos M. Moutsopoulos: a lifetime in autoimmunity.

Authors:  Pierre Youinou
Journal:  J Autoimmun       Date:  2010-07-31       Impact factor: 7.094

5.  Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis.

Authors:  P Das; K M Drescher; A Geluk; D S Bradley; M Rodriguez; C S David
Journal:  Hum Immunol       Date:  2000-03       Impact factor: 2.850

6.  Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.

Authors:  M Minohara; H Ochi; S Matsushita; A Irie; Y Nishimura; J Kira
Journal:  Tissue Antigens       Date:  2001-05

7.  Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.

Authors:  K Kawamura; T Yamamura; K Yokoyama; D H Chui; Y Fukui; T Sasazuki; H Inoko; C S David; T Tabira
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 8.  Genetic factors in multiple sclerosis.

Authors:  J R Oksenberg; A B Begovich; H A Erlich; L Steinman
Journal:  JAMA       Date:  1993-11-17       Impact factor: 56.272

9.  Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.

Authors:  E A Elliott; H I McFarland; S H Nye; R Cofiell; T M Wilson; J A Wilkins; S P Squinto; L A Matis; J P Mueller
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

10.  HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.

Authors:  K Ito; H J Bian; M Molina; J Han; J Magram; E Saar; C Belunis; D R Bolin; R Arceo; R Campbell; F Falcioni; D Vidović; J Hammer; Z A Nagy
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Epistasis and immunity: the role of genetic interactions in autoimmune diseases.

Authors:  Anna M Rose; Lucy C K Bell
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

2.  Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.

Authors:  Daniel Bastardo Blanco; David Luckey; Michele Smart; Mark Pittelkow; Rajiv Kumar; Chella S David; Ashutosh K Mangalam
Journal:  Jacobs J Allergy Immunol       Date:  2014-12

Review 3.  Autoimmunity in 2011.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

Review 4.  HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile.

Authors:  Ashutosh K Mangalam; Veena Taneja; Chella S David
Journal:  J Immunol       Date:  2013-01-15       Impact factor: 5.422

5.  Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.

Authors:  Ashutosh K Mangalam; David Luckey; Shailendra Giri; Michele Smart; Larry R Pease; Moses Rodriguez; Chella S David
Journal:  J Autoimmun       Date:  2012-03-28       Impact factor: 7.094

6.  The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  Young Hee Jin; Hyun Seok Kang; Wanqiu Hou; Liping Meng; Byung S Kim
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

7.  Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease.

Authors:  Ashutosh Mangalam; Shailesh K Shahi; David Luckey; Melissa Karau; Eric Marietta; Ningling Luo; Rok Seon Choung; Josephine Ju; Ramakrishna Sompallae; Katherine Gibson-Corley; Robin Patel; Moses Rodriguez; Chella David; Veena Taneja; Joseph Murray
Journal:  Cell Rep       Date:  2017-08-08       Impact factor: 9.423

Review 8.  The implication of vitamin D and autoimmunity: a comprehensive review.

Authors:  Chen-Yen Yang; Patrick S C Leung; Iannis E Adamopoulos; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

9.  Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.

Authors:  N Marín; H Eixarch; M J Mansilla; E Rodríguez-Martín; M Mecha; C Guaza; J C Álvarez-Cermeño; X Montalban; L M Villar; C Espejo
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

10.  HLA Class II Polymorphisms Modulate Gut Microbiota and Experimental Autoimmune Encephalomyelitis Phenotype.

Authors:  Shailesh K Shahi; Soham Ali; Camille M Jaime; Natalya V Guseva; Ashutosh K Mangalam
Journal:  Immunohorizons       Date:  2021-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.